XML 82 R64.htm IDEA: XBRL DOCUMENT v3.25.3
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 17, 2025
USD ($)
Sep. 16, 2024
USD ($)
Jun. 19, 2024
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
intangibleAsset
Jun. 30, 2025
USD ($)
Finite-Lived Intangible Assets [Line Items]                  
Number of intangible assets acquired | intangibleAsset               2  
Royalty payment percentage     3.125%            
Buyout period     6 months            
Payments for royalties $ 17,300,000                
Amortization of intangible assets       $ 20,400,000 $ 13,900,000 $ 62,200,000 $ 39,800,000    
Gross carrying amount       929,785,000   929,785,000   $ 893,825,000  
Impairment of indefinite lived intangible assets       800,000 $ 0 800,000 $ 0    
Buy Out Option                  
Finite-Lived Intangible Assets [Line Items]                  
Remaining estimated useful lives 12 years                
Acquired ANDAs intangible assets                  
Finite-Lived Intangible Assets [Line Items]                  
Intangible assets acquired       700,000          
Gross carrying amount       $ 214,174,000   $ 214,174,000   $ 210,497,000  
Acquired ANDAs intangible assets | Reclassification Of Assets On Completion Of Project And Launch Of Related Products                  
Finite-Lived Intangible Assets [Line Items]                  
Remaining estimated useful lives                 10 years
Acquired ANDAs intangible assets | In process research and development | Reclassification Of Assets On Completion Of Project And Launch Of Related Products                  
Finite-Lived Intangible Assets [Line Items]                  
Gross carrying amount                 $ 15,800,000
Alimera Sciences, Inc                  
Finite-Lived Intangible Assets [Line Items]                  
Remaining estimated useful lives               12 years  
Alimera Sciences, Inc | YUTIQ                  
Finite-Lived Intangible Assets [Line Items]                  
Intangible assets acquired   $ 170,000           $ 170,000,000  
Remaining estimated useful lives   12 years              
Alimera Sciences, Inc | ILUVIEN                  
Finite-Lived Intangible Assets [Line Items]                  
Intangible assets acquired   $ 230,000           $ 230,000,000  
Remaining estimated useful lives   12 years